|
Aastrom Biosciences, Inc. - Company Profile Snapshot
| Company Profile: |
Aastrom Biosciences, Inc. |
| Ticker: |
ASTM |
| Exchanges: |
NAS |
| 2009 Sales: |
182,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
UNITED STATES |
| Employees: |
48 |
Business Description
Aastrom Biosciences, Inc.. The Group's principal activity is to develop autologous cell products for use in regenerative medicine. Its proprietary Tissue Repair Cell (TRC) technology is based on its cell products which are unique cell mixture containing increased numbers of stem and early progenitor cells, produced from a small amount of bone marrow taken from the patient. The Group intends to pursue TRC-based cell products for the following therapeutic areas: Cardiac tissue regeneration, Vascular tissue regeneration, Bone tissue regeneration and Neural tissue regeneration. The Group has developed a patented manufacturing system to produce human cells for clinical use. This automated cell manufacturing system enables its "single-pass perfusion" cell culture process. The Group operates in the United States, Germany and Spain. It is in the development stage.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
